Pictet-Biotech I dy GBP
SpecialistPricing frequency
Daily
Dealing cut off time
11:00
Type
SICAV
Yield
-
NAV
£824.02
Ongoing charge
1.1%
Latest actual NAV date
17-04-2024
ISIN
LU0448836352
UCITS
Yes
This fund can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Regular investment
Before investing please read:
Growth of 10k
Asset allocation
Top 10 holdings
Holdings 29/02/2024 | % of assets |
---|---|
argenx SE ADR | 3.99 |
Vertex Pharmaceuticals Inc | 3.69 |
Blueprint Medicines Corp | 3.67 |
Biogen Inc | 3.43 |
Sarepta Therapeutics Inc | 3.42 |
Neurocrine Biosciences Inc | 3.26 |
Ionis Pharmaceuticals Inc | 3.16 |
Viking Therapeutics Inc | 3.10 |
Regeneron Pharmaceuticals Inc | 2.96 |
Amgen Inc | 2.89 |
Investment objective
This Compartment applies a capital growth strategy by investing at least two-thirds of its total assets/total wealth in equities or similar securities issued by biopharmaceutical companies throughout the world (including emerging countries). However, in light of the particularly innovative nature of the pharmaceutical industry in North America and Western Europe, the vast majority of investments will be made in these regions. To capitalise on particularly innovative projects in the pharmaceuticals field, the Biotech Compartment may invest up to 10% of its net assets in Private Equity and/or unlisted securities.
Morningstar ratingTM
Morningstar sustainability ratingTM
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.